| 000 | 01116 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517115928.0 | ||
| 264 | 0 | _c20170323 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1558-2035 | ||
| 024 | 7 |
_a10.2459/JCM.0000000000000447 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFarmakis, Dimitrios | |
| 245 | 0 | 0 |
_aNatriuretic peptides revisited: new potentials and challenges in heart failure. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular medicine (Hagerstown, Md.) _cNov 2016 |
||
| 300 |
_a840-2 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNatriuretic Peptides _xblood |
| 650 | 0 | 4 | _aPrognosis |
| 700 | 1 | _aParissis, John | |
| 700 | 1 | _aPapingiotis, George | |
| 700 | 1 | _aLekakis, John | |
| 700 | 1 | _aFilippatos, Gerasimos | |
| 773 | 0 |
_tJournal of cardiovascular medicine (Hagerstown, Md.) _gvol. 17 _gno. 11 _gp. 840-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2459/JCM.0000000000000447 _zAvailable from publisher's website |
| 999 |
_c26463459 _d26463459 |
||